
Ashok Patel
Examiner (ID: 15502, Phone: (571)272-2456 , Office: P/2879 )
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2889, 2879, 2618, 2215, 2875, 2604 |
| Total Applications | 2975 |
| Issued Applications | 2581 |
| Pending Applications | 71 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19417250
[patent_doc_number] => 20240293373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => FORMULATIONS OF BENDAMUSTINE
[patent_app_type] => utility
[patent_app_number] => 18/646329
[patent_app_country] => US
[patent_app_date] => 2024-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18646329
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/646329 | Formulations of bendamustine | Apr 24, 2024 | Issued |
Array
(
[id] => 19417249
[patent_doc_number] => 20240293372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => FORMULATIONS OF BENDAMUSTINE
[patent_app_type] => utility
[patent_app_number] => 18/646171
[patent_app_country] => US
[patent_app_date] => 2024-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18646171
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/646171 | Formulations of bendamustine | Apr 24, 2024 | Issued |
Array
(
[id] => 19388033
[patent_doc_number] => 20240277903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => BIOCOMPATIBLE POLYMER AND MAGNESIUM FOR REGENERATION OF ARTICULAR SURFACES IN THE TEMPOROMANDIBULAR JOINT
[patent_app_type] => utility
[patent_app_number] => 18/639302
[patent_app_country] => US
[patent_app_date] => 2024-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18639302
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/639302 | BIOCOMPATIBLE POLYMER AND MAGNESIUM FOR REGENERATION OF ARTICULAR SURFACES IN THE TEMPOROMANDIBULAR JOINT | Apr 17, 2024 | Pending |
Array
(
[id] => 19359434
[patent_doc_number] => 20240261468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => CARTILAGE GRAFT SCAFFOLDS
[patent_app_type] => utility
[patent_app_number] => 18/636564
[patent_app_country] => US
[patent_app_date] => 2024-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7714
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18636564
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/636564 | CARTILAGE GRAFT SCAFFOLDS | Apr 15, 2024 | Pending |
Array
(
[id] => 20178260
[patent_doc_number] => 20250262218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => COMPOSITIONS, FORMULATIONS AND METHODS FOR STIMULATING RESPIRATION
[patent_app_type] => utility
[patent_app_number] => 18/637263
[patent_app_country] => US
[patent_app_date] => 2024-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18637263
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/637263 | COMPOSITIONS, FORMULATIONS AND METHODS FOR STIMULATING RESPIRATION | Apr 15, 2024 | Abandoned |
Array
(
[id] => 19784146
[patent_doc_number] => 20250057825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/631588
[patent_app_country] => US
[patent_app_date] => 2024-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18631588
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/631588 | CLEVIDIPINE EMULSION FORMULATIONS CONTAINING ANTIMICROBIAL AGENTS | Apr 9, 2024 | Pending |
Array
(
[id] => 19343751
[patent_doc_number] => 20240252714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => METHOD FOR MANUFACTURING BONE-REGENERATION MATERIAL COMPRISING BIODEGRADABLE FIBERS BY USING ELECTROSPINNING METHOD
[patent_app_type] => utility
[patent_app_number] => 18/630735
[patent_app_country] => US
[patent_app_date] => 2024-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18630735
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/630735 | Method for manufacturing bone-regeneration material comprising biodegradable fibers by using electrospinning method | Apr 8, 2024 | Issued |
Array
(
[id] => 19297453
[patent_doc_number] => 20240226018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => METHOD FOR COATING PHARMACEUTICAL SUBSTRATES
[patent_app_type] => utility
[patent_app_number] => 18/613671
[patent_app_country] => US
[patent_app_date] => 2024-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613671
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/613671 | METHOD FOR COATING PHARMACEUTICAL SUBSTRATES | Mar 21, 2024 | Pending |
Array
(
[id] => 19379447
[patent_doc_number] => 20240269317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => TARGETED ENCAPSULATION STRATEGIES FOR TREATMENT MODALITIES
[patent_app_type] => utility
[patent_app_number] => 18/601302
[patent_app_country] => US
[patent_app_date] => 2024-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18601302
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/601302 | TARGETED ENCAPSULATION STRATEGIES FOR TREATMENT MODALITIES | Mar 10, 2024 | Pending |
Array
(
[id] => 19410546
[patent_doc_number] => 12076338
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-09-03
[patent_title] => Devices for treating diseases and conditions
[patent_app_type] => utility
[patent_app_number] => 18/598402
[patent_app_country] => US
[patent_app_date] => 2024-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 19018
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 201
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18598402
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/598402 | Devices for treating diseases and conditions | Mar 6, 2024 | Issued |
Array
(
[id] => 19825300
[patent_doc_number] => 12246054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-11
[patent_title] => Method of treating diseases
[patent_app_type] => utility
[patent_app_number] => 18/599125
[patent_app_country] => US
[patent_app_date] => 2024-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 17027
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18599125
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/599125 | Method of treating diseases | Mar 6, 2024 | Issued |
Array
(
[id] => 19839063
[patent_doc_number] => 12251418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-18
[patent_title] => Method of treating diseases
[patent_app_type] => utility
[patent_app_number] => 18/599127
[patent_app_country] => US
[patent_app_date] => 2024-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 17010
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18599127
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/599127 | Method of treating diseases | Mar 6, 2024 | Issued |
Array
(
[id] => 19263711
[patent_doc_number] => 20240207408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => Solid Solution Compositions and Use in Severe Pain
[patent_app_type] => utility
[patent_app_number] => 18/595716
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18595716
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/595716 | Solid Solution Compositions and Use in Severe Pain | Mar 4, 2024 | Pending |
Array
(
[id] => 19343476
[patent_doc_number] => 20240252439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE AND USE FOR MANUFACTURING PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE
[patent_app_type] => utility
[patent_app_number] => 18/591896
[patent_app_country] => US
[patent_app_date] => 2024-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18591896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/591896 | PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE AND USE FOR MANUFACTURING PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY DAMAGE | Feb 28, 2024 | Pending |
Array
(
[id] => 19767781
[patent_doc_number] => 20250049207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => ANTIMICROBIAL NYLON COMPOSITE MATERIAL, PREPARATION METHOD THEREOF AND APPLICATION IN BRUSHES
[patent_app_type] => utility
[patent_app_number] => 18/588031
[patent_app_country] => US
[patent_app_date] => 2024-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18588031
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/588031 | ANTIMICROBIAL NYLON COMPOSITE MATERIAL, PREPARATION METHOD THEREOF AND APPLICATION IN BRUSHES | Feb 26, 2024 | Pending |
Array
(
[id] => 19430946
[patent_doc_number] => 20240299444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE
[patent_app_type] => utility
[patent_app_number] => 18/444175
[patent_app_country] => US
[patent_app_date] => 2024-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18444175
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/444175 | ENHANCED IMMUNE RESPONSE UPON TREATMENT WITH NITRIC OXIDE | Feb 15, 2024 | Abandoned |
Array
(
[id] => 19186117
[patent_doc_number] => 20240165030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => CENTANAFADINE PHARMACEUTICAL FORMULATIONS, AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/427459
[patent_app_country] => US
[patent_app_date] => 2024-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18427459
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/427459 | Centanafadine pharmaceutical formulations, and methods of making and using same | Jan 29, 2024 | Issued |
Array
(
[id] => 19186218
[patent_doc_number] => 20240165131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/426704
[patent_app_country] => US
[patent_app_date] => 2024-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18426704
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/426704 | TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS | Jan 29, 2024 | Abandoned |
Array
(
[id] => 20787582
[patent_doc_number] => 12661477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-23
[patent_title] => Nitric oxide therapies
[patent_app_type] => utility
[patent_app_number] => 18/421265
[patent_app_country] => US
[patent_app_date] => 2024-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 0
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18421265
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/421265 | Nitric oxide therapies | Jan 23, 2024 | Issued |
Array
(
[id] => 19643220
[patent_doc_number] => 20240417740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA
[patent_app_type] => utility
[patent_app_number] => 18/411482
[patent_app_country] => US
[patent_app_date] => 2024-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18411482
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/411482 | IMMUNISATION OF LARGE MAMMALS WITH LOW DOSES OF RNA | Jan 11, 2024 | Pending |